MARKET

ARAY

ARAY

Accuray Incorp
NASDAQ
2.165
-0.075
-3.35%
Opening 11:45 10/05 EDT
OPEN
2.230
PREV CLOSE
2.240
HIGH
2.230
LOW
2.135
VOLUME
61.97K
TURNOVER
68.11K
52 WEEK HIGH
5.93
52 WEEK LOW
1.700
MARKET CAP
202.60M
P/E (TTM)
-37.4567
1D
5D
1M
3M
1Y
5Y
Accuray launches CyberKnife platform in Africa for cancer patients
Accuray (NASDAQ:ARAY) <a href="https://seekingalpha.com/pr/18959094...
Seekingalpha · 5d ago
Accuray Announced First CyberKnife Systems in Africa
Accuray Incorporated (NASDAQ: ARAY) announced today the company is expanding its global footprint with the introduction of its CyberKnife® platform in Africa, making it possible for more patients to obtain access to the extremely precise stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treat
Benzinga · 5d ago
Accuray Announces First CyberKnife® Systems in Africa, Providing a New Option and Hope for Potentially Life-Saving Radiation Treatments for More Cancer Patients
Accuray Incorporated (NASDAQ: ARAY) announced today the company is expanding its global footprint with the introduction of its CyberKnife® platform in Africa, making it possible for more patients to obtain access to the extremely precise stereotactic radio...
PR Newswire · 5d ago
Dr. Seth Blacksburg Joins Accuray as VP, Chief Medical Officer Americas Region
Accuray Incorporated (NASDAQ: ARAY) announced today that Seth Blacksburg, M.D., MBA has joined the company as vice president, chief medical officer for the Americas (North and South America) region. Dr. Blacksburg will be responsible for bringing the strat...
PR Newswire · 09/14 11:30
Accuray's (ARAY) Latest Collaboration to Improve Patient Care
Accuray (ARAY) partners with Genolier Innovation Hub to unite companies from the MedTech, pharma and biosciences sectors with physicians and scientists for better patient outcomes.
Zacks · 09/08 16:44
BRIEF-Accuray Partners With Swiss-Based Genolier Innovation Hub To Bring Medical And Technological Advances To Patients Faster
BRIEF-Accuray Partners With Swiss-Based Genolier Innovation Hub To Bring Medical And Technological Advances To Patients Faster
Reuters · 09/07 11:35
Accuray's (NASDAQ:ARAY) Returns On Capital Are Heading Higher
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...
Simply Wall St. · 09/05 13:55
Are Options Traders Betting on a Big Move in Accuray (ARAY) Stock?
Investors need to pay close attention to Accuray (ARAY) stock based on the movements in the options market lately.
Zacks · 08/19 11:44
More
About ARAY
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells, and supports solutions that are designed to deliver radiation treatments. Its solutions are designed to advance patient care during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, the Company also provides services, which include post-contract customer support (warranty period services and post warranty services), installation services, training, and other professional services.

Webull offers kinds of Accuray Incorporated stock information, including NASDAQ:ARAY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARAY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ARAY stock methods without spending real money on the virtual paper trading platform.